These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 18774502

  • 1. Fatal liver failure: molecular evidence for chronic active Epstein-Barr virus infection.
    Sánchez F, Gimeno-Bayón JL, Esgueva R, Alvarez F, Munné MA, Serrano S.
    Ann Diagn Pathol; 2008 Oct; 12(5):368-71. PubMed ID: 18774502
    [Abstract] [Full Text] [Related]

  • 2. Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.
    Salama ME, Parham DM, Perkins SL, Bahler DW, Ellison DA.
    Pediatr Dev Pathol; 2008 Oct; 11(6):443-9. PubMed ID: 18473605
    [Abstract] [Full Text] [Related]

  • 3. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K.
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [Abstract] [Full Text] [Related]

  • 4. Fulminant hepatitis due to Epstein-Barr virus infection.
    Papatheodoridis GV, Delladetsima JK, Kavallierou L, Kapranos N, Tassopoulos NC.
    J Hepatol; 1995 Sep; 23(3):348-50. PubMed ID: 8551000
    [Abstract] [Full Text] [Related]

  • 5. The role of Epstein-Barr virus in acute and chronic hepatitis.
    Drebber U, Kasper HU, Krupacz J, Haferkamp K, Kern MA, Steffen HM, Quasdorff M, Zur Hausen A, Odenthal M, Dienes HP.
    J Hepatol; 2006 May; 44(5):879-85. PubMed ID: 16554102
    [Abstract] [Full Text] [Related]

  • 6. Molecular evidence of ocular Epstein-Barr virus infection.
    Slobod KS, Sandlund JT, Spiegel PH, Haik B, Hurwitz JL, Conley ME, Bowman LC, Benaim E, Jenkins JJ, Stocks RM, Gan Y, Sixbey JW.
    Clin Infect Dis; 2000 Jul; 31(1):184-8. PubMed ID: 10913420
    [Abstract] [Full Text] [Related]

  • 7. Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection.
    Kanegane H, Wakiguchi H, Kanegane C, Kurashige T, Miyawaki T, Tosato G.
    Clin Infect Dis; 1999 Apr; 28(4):906-9. PubMed ID: 10825059
    [Abstract] [Full Text] [Related]

  • 8. [Primary infection with Epstein-Barr virus in a 77-year-old patient with B symptoms and hepatitis -- a case report].
    Drebber U, Kasper HU, Odenthal M, Kern MA, Feigk B, Dippold WG, Dienes HP.
    Z Gastroenterol; 2006 May; 44(5):387-90. PubMed ID: 16688655
    [Abstract] [Full Text] [Related]

  • 9. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject.
    Ader F, Chatellier D, Le Berre R, Morand P, Fourrier F.
    Med Mal Infect; 2006 Jul; 36(7):396-8. PubMed ID: 16876362
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
    Hara S, Hoshino Y, Naitou T, Nagano K, Iwai M, Suzuki K, Yamamoto K, Nagasaka T, Morishima T, Kimura H.
    J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
    Shibata Y, Hoshino Y, Hara S, Yagasaki H, Kojima S, Nishiyama Y, Morishima T, Kimura H.
    J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
    [Abstract] [Full Text] [Related]

  • 14. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M, Morita Y, Nakamura N, Shimizu K, Murayama K, Nakamura S.
    Pathol Res Pract; 2008 Jun; 204(4):267-72. PubMed ID: 18187262
    [Abstract] [Full Text] [Related]

  • 15. A case of a long-time survivor with chronic active Epstein-Barr virus infection.
    Takeoka Y, Nakao Y, Ueda M, Koh KR, Aoyama Y, Nakamae H, Yamamura R, Ohta K, Takubo T, Yamane T, Hino M, Tokura Y, Ishihara S, Oshima K, Kimura H, Imashuku S.
    Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients.
    Sonke GS, Ludwig I, van Oosten H, Baars JW, Meijer E, Kater AP, de Jong D.
    Clin Infect Dis; 2008 Jul 01; 47(1):105-8. PubMed ID: 18491961
    [Abstract] [Full Text] [Related]

  • 19. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
    Takashima K, Ohashi M, Kitamura Y, Ando K, Nagashima K, Sugihara H, Okuno K, Sairenji T, Hayashi K.
    J Med Virol; 2008 Mar 01; 80(3):455-66. PubMed ID: 18205213
    [Abstract] [Full Text] [Related]

  • 20. Infiltrations of Epstein-Barr virus-carrying cells in granular lymphocyte-proliferative disorders corresponding to chronic active Epstein-Barr virus infection.
    Takechi T, Maeda A, Hisakawa H, Wakiguchi H, Takeuchi T, Sonobe H, Ohtsuki Y.
    Pediatr Hematol Oncol; 2002 Mar 01; 19(7):459-65. PubMed ID: 12217191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.